Maravai Lifesciences Holdings, Inc. (MRVI)
7.90
+0.40
(+5.33%)
USD |
NASDAQ |
Oct 02, 16:00
7.87
-0.03
(-0.38%)
After-Hours: 20:00
Maravai Lifesciences Holdings Debt to Equity Ratio : 0.8635 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8635 |
| March 31, 2026 | 1.280 |
| December 31, 2025 | 1.717 |
| September 30, 2025 | 1.499 |
| June 30, 2025 | 1.396 |
| March 31, 2025 | 1.087 |
| December 31, 2024 | 1.158 |
| September 30, 2024 | 1.626 |
| June 30, 2024 | 1.286 |
| March 31, 2024 | 1.370 |
| December 31, 2023 | 1.466 |
| September 30, 2023 | 1.184 |
| June 30, 2023 | 1.186 |
| March 31, 2023 | 1.055 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.9789 |
| September 30, 2022 | 1.060 |
| June 30, 2022 | 1.168 |
| March 31, 2022 | 1.385 |
| December 31, 2021 | 1.694 |
| September 30, 2021 | 1.943 |
| June 30, 2021 | 3.033 |
| March 31, 2021 | 5.235 |
| December 31, 2020 | 6.675 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 2.760 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Repligen Corp. | 0.3271 |
| Bio-Techne Corp. | 0.1371 |
| BioLife Solutions, Inc. | 0.0375 |
| MindWalk Holdings Corp. | 0.5041 |
| MaxCyte, Inc. | 0.1087 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 603.75M |
| Total Liabilities (Quarterly) | 248.16M |
| Shareholders Equity (Quarterly) | 204.62M |
| Current Ratio | 4.052 |
| Net Debt Paydown Yield | 3.23% |